165 related articles for article (PubMed ID: 28490049)
1. Comparison of Plasma, Saliva, and Hair Levetiracetam Concentrations.
Karaś-Ruszczyk K; Kuczyńska J; Sienkiewicz-Jarosz H; Kurkowska-Jastrzębska I; Bienkowski P; Restel M; Samochowiec J; Mierzejewski P
Ther Drug Monit; 2017 Jun; 39(3):263-268. PubMed ID: 28490049
[TBL] [Abstract][Full Text] [Related]
2. Comparison of plasma, saliva, and hair lamotrigine concentrations.
Kuczynska J; Karas-Ruszczyk K; Zakrzewska A; Dermanowski M; Sienkiewicz-Jarosz H; Kurkowska-Jastrzebska I; Bienkowski P; Konopko M; Dominiak M; Mierzejewski P
Clin Biochem; 2019 Dec; 74():24-30. PubMed ID: 31672648
[TBL] [Abstract][Full Text] [Related]
3. Saliva and serum levetiracetam concentrations in patients with epilepsy.
Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
[TBL] [Abstract][Full Text] [Related]
4. Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry.
Guo T; Oswald LM; Mendu DR; Soldin SJ
Clin Chim Acta; 2007 Jan; 375(1-2):115-8. PubMed ID: 16914128
[TBL] [Abstract][Full Text] [Related]
5. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring.
Matar KM
J Pharm Biomed Anal; 2008 Nov; 48(3):822-8. PubMed ID: 18603399
[TBL] [Abstract][Full Text] [Related]
6. Comparison of plasma and saliva concentrations of levetiracetam following administration orally as a tablet and as a solution in healthy adult volunteers.
Lins RL; Otoul C; De Smedt F; Coupez R; Stockis A
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):47-54. PubMed ID: 17256450
[TBL] [Abstract][Full Text] [Related]
7. In situ metabolism of levetiracetam in blood of patients with epilepsy.
Patsalos PN; Ghattaura S; Ratnaraj N; Sander JW
Epilepsia; 2006 Nov; 47(11):1818-21. PubMed ID: 17116020
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Contin M; Albani F; Riva R; Baruzzi A
Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of saliva for perampanel therapeutic drug monitoring.
Kim DY; Moon J; Shin YW; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee S; Yu KS; Jang IJ; Song K; Chu K; Lee S
Epilepsia; 2020 Jun; 61(6):1120-1128. PubMed ID: 32378757
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection.
Juenke JM; Brown PI; Johnson-Davis KL; McMillin GA
Ther Drug Monit; 2011 Apr; 33(2):209-13. PubMed ID: 21297550
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
[TBL] [Abstract][Full Text] [Related]
12. Correlation of levetiracetam concentrations between serum and saliva.
Grim SA; Ryan M; Miles MV; Tang PH; Strawsburg RH; deGrauw TJ; Fakhoury TA; Baumann RJ
Ther Drug Monit; 2003 Feb; 25(1):61-6. PubMed ID: 12548146
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
Tan J; Paquette V; Levine M; Ensom MHH
Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
[TBL] [Abstract][Full Text] [Related]
14. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of levetiracetam concentrations in plasma and saliva samples by ultra-performance liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring for pregnant women with epilepsy.
Zhang M; Jin Y; Li W; He C; Di X; Duan Y; Chen L; Wang Z
Biomed Chromatogr; 2024 Feb; 38(2):e5777. PubMed ID: 37990827
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study.
Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B
Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482
[TBL] [Abstract][Full Text] [Related]
17. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India.
Mathew BS; Fleming DH; Thomas M; Prabha R; Saravanakumar K
Neurol India; 2012; 60(2):146-9. PubMed ID: 22626693
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
[TBL] [Abstract][Full Text] [Related]
20. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
Freitas-Lima P; Alexandre V; Pereira LR; Feletti F; Perucca E; Sakamoto AC
Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
